# Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

> **NCT00410280** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** IMA-638 is a biologic

## Key facts

- **NCT ID:** NCT00410280
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410280, "Study Evaluating the Effects of IMA-638 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00410280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*